Cardiovascular, Renal, and Metabolic Effects of SGLT-2 Inhibitors in Type 2 Diabetes Mellitus: A Prospective Cohort Study

More on Inflammation

• Lipid accumulation index linked to cardiometabolic multimorbidity

  The Journal of the Egyptian Public Health Association · 5 Oct 2026

  

• Semaglutide may protect kidneys by reducing vascular resistance

  Nature Medicine · 4 Oct 2026

  

• Survodutide reduces weight in adults with diabetes and obesity

  The New England Journal of Medicine · 4 Oct 2026

• Retatrutide reduces bodyweight in obesity and type 2 diabetes

  Lancet · 4 Oct 2026